Search
Close this search box.

The Heart of a Curse

The Heart of a Curse

As part of a Genome Atlantic project, scientists discovered the genetic marker for “The Newfoundland Curse”, an often-fatal heart disease.  With screening, hundreds of high-risk patients have been identified and many fitted with life-saving defibrillators. Researchers at Memorial University and Janeway Children’s Hospital are continuing this important research to find more answers.

L to R: The ARVC research team of Drs. Terry-Lynn Young, Kathleen Hodgkinson and Sean Connors

More Project Details

Heart disease gene discovery still saving lives

Update: Drs. Terry-Lynn Young, Kathleen Hodgkinson, Sean Connors and Daryl Pullman were awarded a Governor General’s Innovation Award in May 2018 for their groundbreaking work identifying the lethal gene mutation that causes Type 5 ARVC, dubbed the “Newfoundland Curse”.

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a deadly heart condition that runs in families and is a cause of unexpected death in seemingly healthy young people. ARVC is particularly prevalent in Newfoundland and Labrador where it exists in a high proportion of the population, with as many as one in 1,000 people affected.

In 2008, researchers at Memorial University discovered the gene responsible for ARVC. Until the causative gene and mutation were found, families with the disease in their medical histories lived in constant fear of sudden death, which was often the only symptom of the condition. Now, thanks to the research team’s discovery, a simple blood test can diagnose ARVC and prophylactic action can be taken with an implanted defibrillator, to jolt a dangerously frenzied heart beat back into a safe, normal rhythm.

Read More

 

Do you have an idea you'd like to discuss?

Return To All Projects

LET'S DISCUSS YOUR IDEA.

WE FOCUS ON CLIENT LED SOLUTIONS.

BRING US AND IDEA AND WE’LL HELP YOU GET IT INTO ACTION.

LET'S DISCUSS YOUR IDEA.

WE FOCUS ON CLIENT LED SOLUTIONS.

BRING US AND IDEA AND WE’LL HELP YOU GET IT INTO ACTION.